You might want to take a look at PSID, the company they're making a marketing deal with. One analyst in an article I read from I think November of 2014 was predicting the stock will hit $ 0.49 within 12 months (for what thats worth) and Zacks has it rated as a buy as well (again, for what that is worth).

If the product they have (a hand held PCR device used for replicating DNA and RNA segments and a popular tool used in quick disease detection) performs as they expect ( I believe it's in Phase II trials) I think this stock will run. Please, please, do your own DD to see if you agree.... JMHO